Alignment Healthcare (NASDAQ:ALHC) Rating Reiterated by Piper Sandler

Alignment Healthcare (NASDAQ:ALHC – Get Free Report)‘s stock had its “overweight” rating reaffirmed by investment analysts at Piper Sandler in a research report issued on Tuesday, Benzinga reports. They currently have a $10.00 target price on the stock, up from their prior target price of $8.00. Piper Sandler’s price objective would suggest a potential upside […]

Leave a Reply

Your email address will not be published.

Previous post HC Wainwright Reiterates Buy Rating for AnaptysBio (NASDAQ:ANAB)
Next post Akari Therapeutics (NASDAQ:AKTX) Now Covered by StockNews.com